Prkdcberty/Prkdcberty
C57BL/6JAnu-Prkdcberty
|
absent B cells |
J:104190
|
|
absent T cells |
J:104190
|
Prkdcdxnph/Prkdcdxnph
129X1/SvJ
|
abnormal kidney morphology |
J:96632
|
|
glomerulosclerosis |
J:96632
|
|
increased physiological sensitivity to xenobiotic |
J:96632
|
|
increased urine protein level |
J:96632
|
Prkdcdxnph/Prkdcdxnph
BALB/c
|
increased cellular sensitivity to gamma-irradiation |
J:68487
|
Prkdcdxnph/Prkdcdxnph
BALB/cJ
|
abnormal kidney morphology |
J:96632
|
|
glomerulosclerosis |
J:96632
|
|
increased physiological sensitivity to xenobiotic |
J:96632
|
|
increased urine protein level |
J:96632
|
Prkdcdxnph/Prkdcdxnph
involves: BALB/cJ * 129X1/SvJ
|
glomerulosclerosis |
J:96632
|
|
increased urine protein level |
J:96632
|
Prkdcem2(IMPC)Ics/Prkdcem2(IMPC)Ics
C57BL/6N-Prkdcem2(IMPC)Ics/Ics
|
decreased leukocyte cell number |
J:211773
|
|
decreased lymphocyte cell number |
J:211773
|
|
decreased mean corpuscular hemoglobin concentration |
J:211773
|
|
increased circulating phosphate level |
J:211773
|
|
increased eosinophil cell number |
J:211773
|
|
increased monocyte cell number |
J:211773
|
|
increased neutrophil cell number |
J:211773
|
Prkdchanky/Prkdchanky
either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ)
|
cecum inflammation |
J:104190
|
|
colitis |
J:104190
|
|
decreased lymphocyte cell number |
J:104190
|
|
diarrhea |
J:104190
|
|
enlarged mesenteric lymph nodes |
J:104190
|
|
increased bone marrow cell number |
J:104190
|
|
increased plasma cell number |
J:104190
|
|
interstitial pneumonia |
J:104190
|
|
liver inflammation |
J:104190
|
|
lymph node hyperplasia |
J:104190
|
|
myeloid hyperplasia |
J:104190
|
Prkdcm1Anu/Prkdcm1Anu
C57BL/6JAnu-Prkdcm1Anu
|
abnormal lymphocyte morphology |
J:104190
|
Prkdcm1Btlr/Prkdcm1Btlr
C57BL/6J-Prkdcm1Btlr
|
abnormal immune system physiology |
J:178522
|
Prkdcm1Btlr/Prkdcm1Btlr
involves: C57BL/6J
|
abnormal class switch recombination |
J:185495
|
|
decreased B cell number |
J:185495
|
|
decreased IgG level |
J:185495
|
|
decreased IgM level |
J:185495
|
Prkdcm2Btlr/Prkdcm2Btlr
C57BL/6J-Prkdcm2Btlr
|
abnormal B cell physiology |
J:204502
|
|
decreased B cell number |
J:204502
|
|
decreased CD4-positive, alpha-beta T cell number |
J:204502
|
|
decreased CD8-positive, alpha-beta T cell number |
J:204502
|
|
decreased IgG level |
J:204502
|
|
decreased IgM level |
J:204502
|
Prkdcm3Btlr/Prkdcm3Btlr
C57BL/6J-Prkdcm3Btlr
|
decreased IgG level |
J:224665
|
|
impaired humoral immune response |
J:224665
|
Prkdcm4Btlr/Prkdcm4Btlr
C57BL/6J-Prkdcm4Btlr
|
decreased B cell number |
J:255217
|
|
increased B-1b cell number |
J:255217
|
|
increased neutrophil cell number |
J:255217
|
Prkdcm5Btlr/Prkdcm5Btlr
C57BL/6J-Prkdcm5Btlr
|
increased alpha-beta T cell number |
J:255220
|
|
increased CD4-positive, alpha-beta T cell number |
J:255220
|
Prkdcm6Btlr/Prkdcm6Btlr
C57BL/6J-Prkdcm6Btlr
|
decreased CD8-positive, naive alpha-beta T cell number |
J:255221
|
|
increased alpha-beta T cell number |
J:255221
|
|
increased CD4-positive, alpha-beta T cell number |
J:255221
|
|
increased CD8-positive, alpha-beta T cell number |
J:255221
|
Prkdcm7Btlr/Prkdcm7Btlr
C57BL/6J-Prkdcm7Btlr
|
abnormal humoral immune response |
J:255223
|
|
decreased IgG level |
J:255223
|
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:255223
|
PrkdcM8Btlr/Prkdc+
C57BL/6J-PrkdcM8Btlr
|
decreased CD8-positive, alpha-beta T cell number |
J:255224
|
PrkdcM8Btlr/PrkdcM8Btlr
C57BL/6J-PrkdcM8Btlr
|
decreased CD8-positive, alpha-beta T cell number |
J:255224
|
|
increased CD4-positive, alpha-beta T cell number |
J:255224
|
|
increased plasmacytoid dendritic cell number |
J:255224
|
PrkdcM9Btlr/Prkdc+
C57BL/6J-PrkdcM9Btlr
|
decreased B-1a cell number |
J:255268
|
|
decreased effector memory CD4-positive, alpha-beta T cell number |
J:255268
|
|
increased B cell number |
J:255268
|
|
increased B-1b cell number |
J:255268
|
PrkdcM9Btlr/PrkdcM9Btlr
C57BL/6J-PrkdcM9Btlr
|
decreased B-1a cell number |
J:255268
|
|
decreased effector memory CD4-positive, alpha-beta T cell number |
J:255268
|
|
increased B cell number |
J:255268
|
|
increased B-1b cell number |
J:255268
|
PrkdcM10Btlr/Prkdc+
C57BL/6J-PrkdcM10Btlr
|
decreased CD8-positive, alpha-beta T cell number |
J:255269
|
PrkdcM10Btlr/PrkdcM10Btlr
C57BL/6J-PrkdcM10Btlr
|
decreased CD8-positive, alpha-beta T cell number |
J:255269
|
PrkdcM11Btlr/Prkdc+
C57BL/6J-PrkdcM11Btlr
|
enhanced humoral immune response |
J:255270
|
|
increased IgM level |
J:255270
|
PrkdcM11Btlr/PrkdcM11Btlr
C57BL/6J-PrkdcM11Btlr
|
enhanced humoral immune response |
J:255270
|
|
increased IgM level |
J:255270
|
Prkdcm12Btlr/Prkdcm12Btlr
C57BL/6J-Prkdcm12Btlr
|
decreased B cell number |
J:264708
|
|
decreased B-1 B cell number |
J:264708
|
|
decreased CD4-positive, alpha-beta T cell number |
J:264708
|
|
decreased CD8-positive, alpha-beta T cell number |
J:264708
|
|
decreased CD8-positive, naive alpha-beta T cell number |
J:264708
|
|
decreased NK T cell number |
J:264708
|
|
decreased single-positive T cell number |
J:264708
|
|
decreased T cell number |
J:264708
|
|
increased central memory CD4-positive, alpha-beta T cell number |
J:264708
|
|
increased central memory CD8 positive, alpha-beta T cell number |
J:264708
|
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:264708
|
|
increased NK cell number |
J:264708
|
Prkdcm13Btlr/Prkdcm13Btlr
C57BL/6J-Prkdcm13Btlr
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:272441
|
Prkdcm14Btlr/Prkdcm14Btlr
C57BL/6J-Prkdcm14Btlr
|
abnormal CD4-positive T cell differentiation |
J:272442
|
|
increased body weight |
J:272442
|
PrkdcM15Btlr/PrkdcM15Btlr
C57BL/6J-PrkdcM15Btlr
|
decreased B-1 B cell number |
J:272445
|
PrkdcM16Btlr/PrkdcM16Btlr
C57BL/6J-PrkdcM16Btlr
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:272520
|
Prkdcm17Btlr/Prkdcm17Btlr
C57BL/6J-Prkdcm17Btlr
|
increased plasmacytoid dendritic cell number |
J:272521
|
Prkdcm18Btlr/Prkdcm18Btlr
C57BL/6J-Prkdcm18Btlr
|
abnormal B cell differentiation |
J:274730
|
|
abnormal CD4-positive T cell differentiation |
J:274730
|
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:274730
|
|
abnormal T cell differentiation |
J:274730
|
|
decreased alpha-beta T cell number |
J:274730
|
|
decreased B cell number |
J:274730
|
|
decreased B-1 B cell number |
J:274730
|
|
decreased CD4-positive, alpha-beta T cell number |
J:274730
|
|
decreased CD8-positive, alpha-beta T cell number |
J:274730
|
|
decreased CD8-positive, naive alpha-beta T cell number |
J:274730
|
|
increased CD4-positive, alpha-beta T cell number |
J:274730
|
|
increased CD8-positive, alpha-beta T cell number |
J:274730
|
|
increased central memory CD4-positive, alpha-beta T cell number |
J:274730
|
|
increased central memory CD8 positive, alpha-beta T cell number |
J:274730
|
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:274730
|
|
increased effector memory CD8-positive, alpha-beta T cell number |
J:274730
|
|
increased T cell number |
J:274730
|
Prkdcm19Btlr/Prkdcm19Btlr
C57BL/6J-Prkdcm19Btlr
|
abnormal B cell differentiation |
J:274763
|
|
abnormal CD4-positive T cell differentiation |
J:274763
|
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:274763
|
|
abnormal T cell differentiation |
J:274763
|
|
decreased B cell number |
J:274763
|
|
decreased B-1 B cell number |
J:274763
|
|
decreased CD4-positive, alpha-beta T cell number |
J:274763
|
|
decreased CD8-positive, alpha-beta T cell number |
J:274763
|
|
decreased CD8-positive, naive alpha-beta T cell number |
J:274763
|
|
decreased T cell number |
J:274763
|
|
increased central memory CD4-positive, alpha-beta T cell number |
J:274763
|
|
increased central memory CD8 positive, alpha-beta T cell number |
J:274763
|
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:274763
|
|
increased effector memory CD8-positive, alpha-beta T cell number |
J:274763
|
|
increased NK cell number |
J:274763
|
Prkdcscid/Prkdcscid
B6.Cg-Prkdcscid/Sz
|
abnormal complement pathway |
J:22026,
J:34814
|
|
abnormal level of surface class II molecules |
J:34814
|
|
abnormal lymph node B cell domain morphology |
J:34814
|
|
abnormal NK cell physiology |
J:34814
|
|
abnormal Peyer's patch morphology |
J:34814
|
|
abnormal spleen white pulp morphology |
J:34814
|
|
abnormal thymus morphology |
J:34814
|
|
decreased B cell number |
J:34814
|
|
decreased CD4-positive, alpha-beta T cell number |
J:34814
|
|
decreased CD8-positive, alpha-beta T cell number |
J:34814
|
|
decreased immunoglobulin level |
J:34814
|
|
decreased lymphocyte cell number |
J:34814
|
|
decreased pre-B cell number |
J:34814
|
|
decreased T cell number |
J:34814
|
|
increased eosinophil cell number |
J:34814
|
|
increased granulocyte number |
J:34814
|
|
increased macrophage cell number |
J:34814
|
|
increased monocyte cell number |
J:34814
|
|
increased neutrophil cell number |
J:34814
|
|
increased NK cell number |
J:34814
|
|
small Peyer's patches |
J:34814
|
|
small thymus |
J:34814
|
|
spleen hypoplasia |
J:34814
|
|
stomach inflammation |
J:120556
|
|
thymus cyst |
J:34814
|
Prkdcscid/Prkdcscid
C.BKa-Prkdcscid
|
abnormal humoral immune response |
J:6958
|
|
abnormal response to transplant |
J:22026
|
|
abnormal spleen white pulp morphology |
J:6958
|
|
abnormal thymus morphology |
J:6958
|
|
absent B cells |
J:6958
|
|
absent Peyer's patches |
J:6958
|
|
absent pre-B cells |
J:6958
|
|
absent thymus cortex |
J:6958
|
|
decreased B cell proliferation |
J:6958
|
|
decreased IgG level |
J:6958
|
|
decreased immunoglobulin level |
J:6958,
J:22026
|
|
decreased leukocyte cell number |
J:6958
|
|
decreased T cell proliferation |
J:6958
|
|
normal
hematopoietic system phenotype |
J:22026
|
|
normal
immune system phenotype |
J:22026
|
|
increased length of allograft survival |
J:6958,
J:22026
|
|
increased T cell derived lymphoma incidence |
J:6958
|
|
lymph node hypoplasia |
J:6958
|
|
lymphoid hypoplasia |
J:6958
|
|
premature death |
J:6958
|
|
salivary gland inflammation |
J:21965
|
|
small lymphoid organs |
J:6958
|
|
small thymus |
J:6958
|
|
thymus cyst |
J:6958
|
Prkdcscid/Prkdcscid
involves: BALB/c * C57BL/6 * C57BL/Ka
|
abnormal NK cell physiology |
J:115033
|
Prkdcscid/Prkdcscid
involves: BALB/c * C57BL/10ScSn * C57BL/Ka
|
normal
muscle phenotype |
J:125527
|
Prkdcscid/Prkdcscid
involves: BALB/c * C57BL/Ka
|
abnormal intestinal epithelium morphology |
J:126867
|
Prkdcscid/Prkdcscid
NOD.Cg-Prkdcscid
|
abnormal lymph node morphology |
J:22026,
J:109833
|
|
abnormal response to transplant |
J:22026,
J:109833
|
|
abnormal spleen white pulp morphology |
J:22026,
J:109833
|
|
abnormal thymus corticomedullary boundary morphology |
J:22026
|
|
abnormal thymus lobule morphology |
J:22026
|
|
decreased B cell number |
J:22026
|
|
decreased bone marrow cell number |
J:22026
|
|
decreased CD4-positive, alpha-beta T cell number |
J:22026,
J:109833
|
|
decreased CD8-positive, alpha-beta T cell number |
J:22026,
J:109833
|
|
decreased erythrocyte cell number |
J:22026
|
|
decreased immunoglobulin level |
J:22026
|
|
decreased level of surface class I molecules |
J:22026
|
|
decreased lymphocyte cell number |
J:22026
|
|
decreased mature B cell number |
J:109833
|
|
decreased NK cell number |
J:22026
|
|
decreased pre-B cell number |
J:22026
|
|
decreased T cell number |
J:22026
|
|
normal
homeostasis/metabolism phenotype |
J:22026
|
|
impaired complement classical pathway |
J:22026
|
|
impaired natural killer cell mediated cytotoxicity |
J:22026
|
|
increased cellular sensitivity to X-ray irradiation |
J:109833
|
|
increased granulocyte number |
J:22026
|
|
increased length of allograft survival |
J:22026
|
|
increased macrophage cell number |
J:22026
|
|
increased mean corpuscular volume |
J:22026
|
|
increased T cell derived lymphoma incidence |
J:22026,
J:109833
|
|
premature death |
J:22026,
J:109833
|
|
spleen hypoplasia |
J:22026,
J:109833
|
|
thymus cyst |
J:22026
|
Prkdcscid/Prkdcscid
NOD.Cg-Prkdcscid/J
|
abnormal response to transplant |
J:91764
|
|
increased circulating glucose level |
J:91764
|
PrkdcTg(INS-PDE2)5-1Lmb/?
involves: FVB/N
|
abnormal thymus morphology |
J:108405
|
|
increased cellular sensitivity to gamma-irradiation |
J:108405
|
|
increased mortality induced by gamma-irradiation |
J:108405
|
Prkdctm1.1Bpcc/Prkdc+
involves: 129 * C57BL/6
|
hyperpigmentation |
J:171351
|
Prkdctm1.1Bpcc/Prkdctm1.1Bpcc
involves: 129 * C57BL/6
|
abnormal DNA repair |
J:171351
|
|
abnormal hematopoietic stem cell physiology |
J:171351
|
|
abnormal immunoglobulin V(D)J recombination |
J:171351
|
|
arrested B cell differentiation |
J:171351
|
|
decreased bone marrow cell number |
J:171351
|
|
decreased CD4-positive, alpha-beta T cell number |
J:171351
|
|
decreased CD8-positive, alpha-beta T cell number |
J:171351
|
|
decreased double-negative T cell number |
J:171351
|
|
decreased double-positive T cell number |
J:171351
|
|
decreased erythrocyte cell number |
J:171351
|
|
decreased gamma-delta T cell number |
J:171351
|
|
decreased granulocyte number |
J:171351
|
|
decreased hematopoietic stem cell number |
J:171351
|
|
decreased leukocyte cell number |
J:171351
|
|
decreased lymphocyte cell number |
J:171351
|
|
decreased macrophage cell number |
J:171351
|
|
decreased mature B cell number |
J:171351
|
|
decreased T cell number |
J:171351
|
|
hyperpigmentation |
J:171351
|
|
increased cellular sensitivity to alkylating agents |
J:171351
|
|
increased cellular sensitivity to ionizing radiation |
J:171351
|
|
increased cellular sensitivity to ultraviolet irradiation |
J:171351
|
|
increased mortality induced by ionizing radiation |
J:171351
|
|
increased sensitivity to induced cell death |
J:171351
|
|
increased small intestinal crypt cell apoptosis |
J:171351
|
|
pallor |
J:171351
|
|
pancytopenia |
J:171351
|
|
postnatal lethality, incomplete penetrance |
J:171351
|
|
premature death |
J:171351
|
|
slow postnatal weight gain |
J:171351
|
|
small lymphoid organs |
J:171351
|
|
thrombocytopenia |
J:171351
|
Prkdctm1Fwa/Prkdctm1Fwa
involves: 129S6/SvEvTac
|
decreased splenocyte number |
J:306598
|
|
normal
nervous system phenotype |
J:110848
|
Prkdctm1Fwa/Prkdctm1Fwa
involves: 129S6/SvEvTac * C57BL/6
|
abnormal T cell receptor beta chain V(D)J recombination |
J:50221
|
|
abnormal T cell receptor V(D)J recombination |
J:50221
|
|
absent pre-B cells |
J:50221
|
|
arrested B cell differentiation |
J:50221
|
|
arrested T cell differentiation |
J:50221
|
|
decreased double-positive T cell number |
J:50221
|
|
decreased thymocyte number |
J:50221
|
|
increased cellular sensitivity to ionizing radiation |
J:50221
|
Prkdctm1Gcl/Prkdctm1Gcl
involves: 129S1/Sv
|
normal
cellular phenotype |
J:126920
|
|
decreased thymocyte apoptosis |
J:126920
|
Prkdctm1Gcl/Prkdctm1Gcl
involves: 129S1/Sv * C57BL/6
|
abnormal colon morphology |
J:53765
|
|
abnormal immunoglobulin heavy chain V(D)J recombination |
J:53765
|
|
abnormal large intestine crypts of Lieberkuhn morphology |
J:53765
|
|
abnormal lymph node morphology |
J:53765
|
|
abnormal spleen morphology |
J:53765
|
|
abnormal T cell receptor beta chain V(D)J recombination |
J:53765
|
|
abnormal T cell receptor delta chain V(D)J recombination |
J:53765
|
|
absent mature B cells |
J:53765
|
|
absent Peyer's patches |
J:53765
|
|
absent thymus corticomedullary boundary |
J:53765
|
|
arrested B cell differentiation |
J:53765
|
|
increased cellular sensitivity to gamma-irradiation |
J:53765
|
|
increased T cell derived lymphoma incidence |
J:53765
|
|
intestine polyps |
J:53765
|
|
preneoplasia |
J:53765
|
|
small lymph nodes |
J:53765
|
|
small Peyer's patches |
J:53765
|
|
small spleen |
J:53765
|
|
small thymus |
J:53765
|
|
thymus hypoplasia |
J:53765
|
Prkdctm1Get/Prkdctm1Get
involves: 129S4/SvJae * Black Swiss
|
abnormal B cell differentiation |
J:50222
|
|
abnormal immunoglobulin heavy chain V(D)J recombination |
J:50222
|
|
abnormal immunoglobulin light chain V-J recombination |
J:50222
|
|
abnormal T cell differentiation |
J:50222
|
|
abnormal T cell number |
J:50222
|
|
abnormal T cell receptor alpha chain V-J recombination |
J:50222
|
|
abnormal T cell receptor beta chain V(D)J recombination |
J:50222
|
|
abnormal T cell receptor delta chain V(D)J recombination |
J:50222
|
|
abnormal thymus corticomedullary boundary morphology |
J:50222
|
|
arrested B cell differentiation |
J:50222
|
|
arrested T cell differentiation |
J:50222
|
|
decreased IgM level |
J:50222
|
|
decreased single-positive T cell number |
J:50222
|
|
decreased spleen white pulp amount |
J:50222
|
|
increased cellular sensitivity to gamma-irradiation |
J:50222
|
|
increased double-negative T cell number |
J:50222
|
|
increased double-positive T cell number |
J:50222
|
|
increased NK cell number |
J:50222
|
|
small lymph nodes |
J:50222
|
|
spleen hypoplasia |
J:50222
|
|
thymus hypoplasia |
J:50222
|
Excel File
Analysis Tools